Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCL
Clinical trial NCT07643805 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07643805
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-01-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.